Can-Fite BioPharma Ltd.

CANF | AMEX

Price Alert Chart Builder DCF Calculator

$2.22

-$0.02 (-0.89%)

At close: Sep 21, 2026, 4:00 PM ET

$2.26

+$0.04 (+1.74%)

Pre-market: Sep 22, 2026, 6:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021	Q4 2020 Dec 30, 2020	Q3 2020 Sep 29, 2020	Q2 2020 Jun 29, 2020	Q1 2020 Mar 30, 2020
Net Income	-8.8M	-8.34M	-7.88M	-7.57M	-7.37M	-7.06M	-7.63M	-9M	-9.77M	-10.29M	-10.17M	-11.27M	-12.14M	-13.17M	-12.62M	-12.13M	-11.31M	-11.98M	-14.44M	-15.59M	-15.97M	-15.14M
Depreciation & Amortization	29K	18K	7K	4K	1K	500	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	420K	391K	362K	538.5K	359K	357.5K	261K	263K	223K	263K	263K	466K	367K	466K	466K	355K	490K	355K	355K	385K	333K	385K
Other Working Capital	-22K	-65.5K	-109K	-376.5K	-644K	-322K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	19K	1K	-17K	1.57M	3.62M	5.01M	7.37M	8.74M	9.55M	10.03M	9.91M	10.81M	11.78M	12.71M	12.15M	11.78M	10.82M	11.62M	14.09M	15.21M	15.63M	14.75M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-22K	-65.5K	-109K	-376.5K	-644K	-322K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Cash Flow	-8.35M	-7.99M	-7.64M	-5.84M	-4.13M	-2.02M	n/a	263K	223K	263K	263K	n/a	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Capital Expenditures	-2K	-3.5K	-5K	-4.5K	-4K	-2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	750K	1.5M	3M	4.5M	2.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-2K	746.5K	1.5M	3M	4.5M	2.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	10.08M	8.4M	6.71M	3.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	10.08M	8.4M	6.71M	3.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Cash Flow	-4.72M	n/a	n/a	n/a	4.62M	n/a	n/a	263K	223K	263K	263K	n/a	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	-8.36M	-8M	-7.64M	-5.84M	-4.13M	-2.02M	n/a	263K	223K	263K	263K	n/a	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Adj. Free Cash Flow	-8.78M	-8.39M	-8M	-6.38M	-4.49M	-2.38M	-261K	n/a	n/a	n/a	n/a	-466K	-232K	-466K	-466K	-355K	-490K	-355K	-355K	-385K	-333K	-385K
Maintenance CapEx	-1.5K	-3K	-4.5K	-4.5K	-4K	-2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	-500	-500	-500	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-8.35M	-8M	-7.64M	-5.84M	-4.13M	-2.02M	n/a	263K	223K	263K	263K	n/a	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a